Economical analyses in interventional radiology;Ökonomische analysen in der interventionellen radiologie

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 174, Issue 2, 2002, Pages 149-159

  Duda, Stephan Hoyt ^a   Feuls, R ^a   De Jong, P ^b   Greiner, W ^c   Pusich, B ^a   Banz, K ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JOHNSON AND JOHNSON   (United States)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d Outcomes International   (Switzerland)

Author keywords

Cost benefit analysis; Cost effectiveness analysis; Interventional radiology; PTA; Stent

Indexed keywords

METAL;

ABDOMINAL AORTA ANEURYSM; BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HUMAN; ILIAC ARTERY OBSTRUCTION; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; KIDNEY ARTERY STENOSIS; NEURORADIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; STENT; VENA CAVA FILTER; BLOOD VESSEL PROSTHESIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ECONOMICS; FIBRINOLYTIC THERAPY; INTERNET; MIDDLE AGED; MULTICENTER STUDY; PORTOSYSTEMIC ANASTOMOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TIME;

ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS; COST-BENEFIT ANALYSIS; HUMANS; INTERNET; MIDDLE AGED; MULTICENTER STUDIES; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RADIOLOGY, INTERVENTIONAL; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; STENTS; THROMBOLYTIC THERAPY; TIME FACTORS; VENA CAVA FILTERS;

EID: 0036483167     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20101     Document Type: Review

References (46)

1. Decision analysis in radiology using Markov models
2. Cochrane Collaborative Review Group on peripheral vascular diseases: Review abstract
3. Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA)
4. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease
5. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease
6. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989
7. Therapeutic alternatives for subacute peripheral arterial occlusion. Comparison by outcome, length of stay, and hospital charges
8. Thrombolysis versus surgery as the initial management for native artery occlusion: Efficacy, safety, and cost
9. Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion
10. kosten-nutzen-analyse renaler revaskularisationen mittels operativer und nicht-operativer verfahren
11. Cost-effectiveness analysis of treatment of renal artery stenoses by medication, angioplasty, stenting, and surgery
12. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial
13. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis
14. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: Rationale, design and inclusion data
15. Hospital costs of revascularization procedures for femoropopliteal arterial disease
16. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis
17. Cost and patency rate targets for the development of endovascular devices to treat femoropopliteal disease
18. The cost-effectiveness of treatment of short occlusive lesions in the femoropopliteaI artery: Balloon angioplasty versus endarterectomy
19. Aortoiliac stent deployment versus surgical reconstruction: Analysis of outcome and cost
20. Iliac occlusions: Stenting or crossover grafting? An examination of patency and cost
21. Balloon angioplasty with intraluminal stenting as the initial treatment modality in aortoiliac occlusive disease
22. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease
23. Intraarterial pressure gradients after randomized angioplasty or stenting of iliac artery lesions
24. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States
25. Iliac arterial occlusive disease: Cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty
26. Endovascular AAA treatment: Expensive prestige or economic alternative?
27. Hospital cost of endovascular versus open repair of abdominal aortic aneurysms: A multicenter study
28. Transjugular intrahepatic portosystemic shunt versus Hgraft portocaval shunt in the management of bleeding varices: A costbenefit analysis
29. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding
30. Cost-effective method for bedside insertion of vena caval filters in trauma patients
31. Preliminary results of bedside inferior vena cava filter placement: Safe and cost-effective
32. Cost vs value in vena caval filters
33. Radiologic versus surgical placement of vena cava filters: A comparative study of cost, time and complications
34. Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: A risky business
35. Common bile duct obstruction due to malignancy: Treatment with plastic versus metal stents
36. Palliation of unresectable pancreatic malignant biliary obstruction: Results of a randomized trial comparing percutaneously placed metal and plastic endoprostheses
37. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial
38. Management of occluded biliary Wallstents
39. A controlled trial of an expansive metal stent for palliation of esophageal obstruction due to inoperable cancer
40. A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors
41. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy
42. Thrombolysis versus surgical thrombectomy for the treatment of dialysis graft thrombosis: Pilot study comparing costs
43. Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts
44. Endovascular versus surgical treatment for thrombosed hemodialysis grafts: A prospective, randomized study
45. Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance
46. Cost-effectiveness analysis of treatment of subacute peripheral artery occlusions with thrombolysis with and without adjunctive abciximab